Author Topic: (Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation  (Read 62 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8565
  • MS diagnosed 1980
  • Location: Pacific Northwest

From PubMed, December 17, 2018--"Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation":


https://www.ncbi.nlm.nih.gov/pubmed/30554038

Daclizumab (Zinbryta) has been taken off the market. For some background, here is a thread from a few months ago about it:


https://msspeaks.createaforum.com/treatments/zinbryta-being-pulled-from-market-due-to-safety-concerns/msg2172/#msg2172

MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
124 Views
Last post December 26, 2018, 11:46:15 am
by agate
0 Replies
67 Views
Last post August 03, 2018, 09:29:58 pm
by agate
0 Replies
23 Views
Last post December 22, 2019, 08:50:14 pm
by agate
0 Replies
4 Views
Last post May 15, 2020, 12:36:31 pm
by agate
0 Replies
8 Views
Last post May 18, 2020, 04:38:30 pm
by agate